Pharmacotherapy and psychotherapy for body dysmorphic disorder

Ipser, Jonathan; Sander, C; Stein, Dan J.

doi:10.1002/14651858.cd005332.pub2

Cited by 94 publications

(50 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, comorbidity rates are high for OCD and BDD, and the prevalence of BDD is elevated in firstdegree relatives of individuals with OCD [17]. Other lines of evidence suggest that BDD shows similarities with OCD in terms of its neural substrates [33] and preferential response to treatment with SSRIs and with CBT/ERP [34]. However, insight is typically much poorer in BDD than in OCD [32].…”

Section: Body Dysmorphic Disordermentioning

confidence: 99%

From anxiety to compulsivity – a review of changes to OCD classification in DSM-5 and ICD-11

Krzanowska¹,

Kuleta²

2017

Arch Psych Psych

View full text Add to dashboard Cite

SummaryObsessive-compulsive disorder (OCD) is no longer classified as an anxiety disorder in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). It has become a flagship disorder of the new category of Obsessive Compulsive and Related Disorders (OCRDs) -a group of five disorders linked together by the core symptom of repetitive thoughts and behaviors and phenomenological and neurobiological similarity to OCD. Body dysmorphic disorder, hoarding disorder, trichotillomania, and skin picking disorder are the other disorders included in this group. In the upcoming eleventh edition of the International Classification of Diseases (ICD)-11, the World Health Organization (WHO) is planning to introduce similar changes to its own classification of OCD, further recommending the inclusion of olfactory reference disorder and hypochondriasis, in addition to the disorders listed in the DSM-5. In this article, we will review the classifications of OCD and OCDRs in the DSM-5 and the upcoming ICD-11, as well as describe the rationale and research leading to the creation of this new class of disorders.

show abstract

Section: Body Dysmorphic Disordermentioning

confidence: 99%

From anxiety to compulsivity – a review of changes to OCD classification in DSM-5 and ICD-11

Krzanowska¹,

Kuleta²

2017

Arch Psych Psych

View full text Add to dashboard Cite

show abstract

“…Also for skin picking (dermatillomania) effective treatments have been developed, which use among other things habit reversal and cognitive restructuring techniques [64,65]. For body dysmorphic disorder, effective behavioral therapies have been developed, which focus on exposure to (fear triggering) social stimuli, response prevention (for example looking at oneself in the mirror, omitting superfluous make-up) and changing irrational beliefs and cognitions about one's own appearance [66,67].…”

Section: Treatments Of Psychiatric Problems In Dermatological Practicementioning

confidence: 99%

Psychological Treatments for Dermatological Conditions

2016

Skin and Psyche

View full text Add to dashboard Cite

Abstract:The impact of dermatological conditions on a patient's life is frequently underestimated. Patients with skin conditions experience several physical complaints, including itch, pain and fatigue. Furthermore, in comparison to the general population, patients report a decreased psychological well-being, lowered quality of life and feelings of stigmatization and shame. Psychological treatments are widely used in addition to regular dermatological treatments to improve physical and psychological functioning of patients with chronic skin conditions. These treatments are usually aimed at changing the psychosocial factors that can influence the onset and/or course of skin conditions, such as dysfunctional coping behaviors, itch-scratching problems and stress. There are unimodal interventions in which single treatments are used, for example psychoeducation or relaxation exercises, and multimodal treatments in which a variety of different interventions are applied based on cognitive-behavioral therapy and self-management principles. Furthermore, a distinction can be made between interventions that focus primarily on skin-related psychosocial problems, interventions that focus on itch-scratching problems, and interventions that are focused on psychiatric problems in the dermatological practice. This chapter gives an overview on the psychosocial factors relevant for dermatological conditions, relevant diagnostic methods and the content and scientific evidence of specific psychological treatments in these different categories.

show abstract

“…Psychopharmacologic trials have mainly focused on selective serotonin reuptake inhibitors (SSRIs) such as citalopram [32], escitalopram [33], clomipramine [34], fluvoxamine [35,36], and fluoxetine [37], which seem to be effective at reducing BDD symptom severity [38].…”

Section: Effective Treatments For Individuals With Body Dysmorphic DImentioning

confidence: 99%

“…Recently, a meta-analysis showed that both pharmacotherapy (particularly SSRIs) and CBT were effective in treating BDD [38,39]. Interestingly, five of the nine psychotherapy studies had completion rates of 100%, indicating that CBT is very acceptable to individuals with BDD [39].…”

Section: Effective Treatments For Individuals With Body Dysmorphic DImentioning

confidence: 99%

Perceived Ugliness: An Update on Treatment-Relevant Aspects of Body Dysmorphic Disorder

Buhlmann

Winter

2011

Curr Psychiatry Rep

View full text Add to dashboard Cite

Despite increased awareness of body dysmorphic disorder (BDD) during the past two decades, it is still a relatively unknown and understudied disorder. Its hallmark is a preoccupation with perceived defects or flaws in one's own appearance, often tied to the face (eg, nose, skin). BDD sufferers often think about their appearance "flaws" for up to several hours daily and frequently engage in ritualistic behaviors such as mirror checking, hair combing, comparing, asking for reassurance, makeup application, or skin picking. Furthermore, avoidance behaviors such as mirror avoidance or the avoidance of social activities are also common. In this paper, we provide an overview of BDD's unique symptomatology, its prevalence, and the comorbidities associated with it. A further aim is to provide an overview of effective treatments and possible obstacles and barriers to seeking or adhering to appropriate mental health care.

show abstract

Pharmacotherapy and psychotherapy for body dysmorphic disorder

Abstract: Analysis 2.1. Comparison 2 Pharmacotherapy versus placebo (secondary outcomes), Outcome

Cited by 94 publications

References 69 publications

From anxiety to compulsivity – a review of changes to OCD classification in DSM-5 and ICD-11

From anxiety to compulsivity – a review of changes to OCD classification in DSM-5 and ICD-11

Psychological Treatments for Dermatological Conditions

Perceived Ugliness: An Update on Treatment-Relevant Aspects of Body Dysmorphic Disorder

Contact Info

Product

Resources

About